Track topics on Twitter Track topics that are important to you
Ideon Science ParkSölvegatan 41
Phone: +46 (0)46 286 57 30
Fax: +46 (0)46 286 57 39
LUND, Sweden, Dec. 23, 2018 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) announced today that the US Food and Drug Administration (FDA) has issued Camurus' US Read more...
LUND, Sweden, Dec. 23, 2018 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) announced today that the US Food and Drug Administration (FDA) has issued Camurus' US partner Braeburn a tentative approval o...
STOCKHOLM, Feb. 6, 2019 /PRNewswire/ -- "The approval of Buvidal is a major milestone for Camurus and an important validation of our innovative FluidCrystal technology." Business highlights fourth...
Camurus and Braeburn's Brixadi, or buprenorphine, extended-release injection for weekly and monthly subcutaneous use in patie -More-
LUND, Sweden, June 20, 2019 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX), a commercial stage biopharmaceutical company specializing in long-acting medicines for severe and chronic disorders, announc...
LUND, Sweden, Feb. 1, 2019 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the Company will release its full year report on 6 February at 7:00 am CET. The report will be available ...
With effect from March 11, 2019, the subscription rights in Camurus AB will be quoted on the list for Equity rights. Quotation will continue up until and including March 21, 2019. Instrument: Subsc...
Camurus redovisar fas 3-data för Buvidal.
Local analgesic effect of a bioadhesive barrier-forming oral liquid in cancer patients with oral mucositis caused by chemotherapy and/or radiotherapy: a randomized multicenter, single-use, positive-controlled, open-label study.
CAM2028 (Episil; Camurus AB, Lund, Sweden) is a liquid for use in the oral cavity to treat various pains associated with mouth injuries. Upon contact with the swollen oral mucosa, the oral liquid form...
Camurus is a drug delivery company, within the healthcare sector, that specializes in formulation technologies of sparingly water soluble drug substances. Camurus offer proprietary technology platform...
Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare diseases. The Co...
Solasia was formed in November 2006 by MPM Capital and ITOCHU Corporation to address unmet needs for important new Western oncology therapies and supportive care products througho...
We have published hundreds of Camurus AB news stories on BioPortfolio along with dozens of Camurus AB Clinical Trials and PubMed Articles about Camurus AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Camurus AB Companies in our database. You can also find out about relevant Camurus AB Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...